Evaluation of substituted pyrazole-based kinase inhibitors in one decade (2011–2020): Current status and future prospects

MI El-Gamal, SO Zaraei, MM Madkour, HS Anbar - Molecules, 2022 - mdpi.com
Pyrazole has been recognized as a pharmacologically important privileged scaffold whose
derivatives produce almost all types of pharmacological activities and have attracted much …

Recent progress of benzimidazole hybrids for anticancer potential

MJ Akhtar, MS Yar, VK Sharma, AA Khan… - Current Medicinal …, 2020 - benthamdirect.com
This review presents the detailed account of factors leading to cancer and design strategy
for the synthesis of benzimidazole derivatives as anticancer agents. The recent survey for …

A Comprehensive In Silico Exploration of Pharmacological Properties, Bioactivities, Molecular Docking, and Anticancer Potential of Vieloplain F from Xylopia vielana …

SS Hassan, SQ Abbas, F Ali, M Ishaq, I Bano… - Molecules, 2022 - mdpi.com
Compounds derived from plants have several anticancer properties. In the current study,
one guaiane-type sesquiterpene dimer, vieloplain F, isolated from Xylopia vielana species …

[HTML][HTML] Identification of benzothiazoles bearing 1, 3, 4-thiadiazole as antiproliferative hybrids targeting VEGFR-2 and BRAF kinase: design, synthesis, BIO evaluation …

WA Ewes, SS Tawfik, AM Almatary, M Ahmad Bhat… - Molecules, 2024 - mdpi.com
Cancer remains a leading cause of death worldwide, often resulting from uncontrolled
growth in various organs. Protein kinase inhibitors represent an important class of targeted …

Computational exploration of anti-cancer potential of guaiane dimers from Xylopia vielana by targeting B-RAF kinase using chemo-informatics, molecular docking, and …

S Shams ul Hassan, SQ Abbas… - Anti-Cancer Agents in …, 2022 - ingentaconnect.com
Background: Natural products from herbs are abundant and display powerful anti-cancer
activities. Objectives: In the current study, B-Raf kinase protein (PDB: 3OG7), a potent target …

[HTML][HTML] Virtual screening, pharmacokinetic, and DFT studies of anticancer compounds as potential V600E-BRAF kinase inhibitors

AB Umar, A Uzairu - Journal of Taibah University Medical Sciences, 2023 - Elsevier
MAPK signaling is a key regulator of fundamental cellular processes such as growth,
proliferation, differentiation, migration, and apoptosis. 1, 2 Signal transmission is enabled by …

Evolution in medicinal chemistry of sorafenib derivatives for hepatocellular carcinoma

F Chen, Y Fang, R Zhao, J Le, B Zhang… - European Journal of …, 2019 - Elsevier
Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. Traditional
chemotherapy drugs are hard to reach a satisfactory therapeutic effect since advanced HCC …

Synthesis, antitumor activity and molecular docking study of some novel 3-benzyl-4 (3H) quinazolinone analogues

IA Al-Suwaidan, AAM Abdel-Aziz… - Journal of enzyme …, 2016 - Taylor & Francis
A novel series of 3-benzyl-substituted-4 (3 H)-quinazolinones were designed, synthesized
and evaluated for their in vitro antitumor activity. The results of this study demonstrated that 2 …

Biological activity evaluation and structure–activity relationships analysis of ferulic acid and caffeic acid derivatives for anticancer

W Li, N Li, Y Tang, B Li, L Liu, X Zhang, H Fu… - Bioorganic & Medicinal …, 2012 - Elsevier
The anticancer activities of alkyl esters and NO-donors of ferulic acid (FA) and caffeic acid
(CA) were assessed by a high-throughout screening (HTS) method, and the structure …

Docking-based strategy to design novel flavone-based arylamides as potent V600E-BRAF inhibitors with prediction of their drug-likeness and ADMET properties

AB Umar, A Uzairu, GA Shallangwa, S Uba - Bulletin of the National …, 2020 - Springer
Abstract Background V600E-BRAF protein target has much potential for scientific research
as therapeutic target due to its involvement in human melanoma cancer. In the current …